Showing 1,801 - 1,820 results of 4,566 for search '(( significant decrease decrease ) OR ( significantly enhanced decrease ))~', query time: 0.46s Refine Results
  1. 1801

    Table 3_Patient-needs-enhanced emergency nursing assessment framework accelerates time-critical care for non-traumatic chest pain.docx by Yan Sun (22436)

    Published 2025
    “…</p>Conclusions<p>Augmenting ENAF with a structured clinical-needs module significantly accelerates ECG acquisition, improves other process metrics and enhances nursing documentation while maintaining patient safety. …”
  2. 1802

    Table 1_Patient-needs-enhanced emergency nursing assessment framework accelerates time-critical care for non-traumatic chest pain.docx by Yan Sun (22436)

    Published 2025
    “…</p>Conclusions<p>Augmenting ENAF with a structured clinical-needs module significantly accelerates ECG acquisition, improves other process metrics and enhances nursing documentation while maintaining patient safety. …”
  3. 1803

    Table 2_Patient-needs-enhanced emergency nursing assessment framework accelerates time-critical care for non-traumatic chest pain.docx by Yan Sun (22436)

    Published 2025
    “…</p>Conclusions<p>Augmenting ENAF with a structured clinical-needs module significantly accelerates ECG acquisition, improves other process metrics and enhances nursing documentation while maintaining patient safety. …”
  4. 1804
  5. 1805

    Data extraction information. by Siyuan Chen (200219)

    Published 2025
    “…Meta-analysis suggested a significant superiority of biologic agents in prolonging relapse-free survival, increasing glucocorticoid taper rate, and decreasing cumulative glucocorticoids dose for both GCA and TAK. …”
  6. 1806

    ROB 2.0 for RCT. by Siyuan Chen (200219)

    Published 2025
    “…Meta-analysis suggested a significant superiority of biologic agents in prolonging relapse-free survival, increasing glucocorticoid taper rate, and decreasing cumulative glucocorticoids dose for both GCA and TAK. …”
  7. 1807

    All studies identified in the literature search. by Siyuan Chen (200219)

    Published 2025
    “…Meta-analysis suggested a significant superiority of biologic agents in prolonging relapse-free survival, increasing glucocorticoid taper rate, and decreasing cumulative glucocorticoids dose for both GCA and TAK. …”
  8. 1808

    Primers used in present study. by Razia Liaqat (17873634)

    Published 2025
    “…Compared to the positive control, interleukin-6 levels were significantly reduced (P < 0.05) in all treatments. Superoxide dismutase and catalase activity increased in response to the bacterial challenge, while malondialdehyde levels gradually decreased. …”
  9. 1809

    Source data for Fig 2. by Qi Xu (134661)

    Published 2025
    “…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …”
  10. 1810

    Source data for lung metabolomics. by Qi Xu (134661)

    Published 2025
    “…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …”
  11. 1811

    Source data for Fig 5. by Qi Xu (134661)

    Published 2025
    “…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …”
  12. 1812

    Source data for Fig 1. by Qi Xu (134661)

    Published 2025
    “…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …”
  13. 1813

    Flow cytometry gating strategy for MDSC. by Qi Xu (134661)

    Published 2025
    “…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …”
  14. 1814

    Source data for Fig 3. by Qi Xu (134661)

    Published 2025
    “…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …”
  15. 1815

    Source data for Fig 4. by Qi Xu (134661)

    Published 2025
    “…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …”
  16. 1816
  17. 1817
  18. 1818
  19. 1819

    Data relevant to the study. by Patcharin Tepjanta (18165111)

    Published 2025
    “…Analysis conducted using the IEDB server indicated that the N320P mutation increased the antigenic index, whereas the N320C mutation significantly decreased it. Conversely, the N320K and N320Q mutations exhibited minor effects on antigenicity. …”
  20. 1820

    S1 File - by Luqiong Liu (11537092)

    Published 2024
    “…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”